Polish biotech Noctiluca wins NCBR Eurostars-3 co-financing for innovative SMEs project

Polish company Noctiluca S.A. has been selected by the National Centre for Research and Development (NCBR) for co-financing under the Eurostars-3 program, which supports R&D by innovative SMEs. The update to report 24/2026 confirms the award but provides no financial details. This is a routine grant announcement with limited market impact, though it signals continued public support for the firm's innovation pipeline.

AI disclosure: Model-written summary of the source, not a verified fact. Check the sources. How Mosaic works